Epilepsy Having Focal Onset Seizures — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for epilepsy having focal onset seizures. 12 active patents protecting 1 drugs from 1+ originators. First major cliff: 2032. Daily refresh.

Originators in Epilepsy Having Focal Onset Seizures

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating epilepsy having focal onset seizures. Each bar = one year. Y-axis scaled to peak year (6 patents).

Approved drugs ranked by patent estate

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Related

• Epilepsy Having Focal Onset Seizures — full disease profile
• AI Patent Landscape Report — type "epilepsy having focal onset seizures" for an AI exec memo
• Company Patent Rankings
• Biosimilar Opportunity Scanner